ResMed Inc. (RMD) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ResMed Inc. (RMD:NYSE), powered by AI.

Current Price
$193.94
Sector
Healthcare
What is the ResMed Inc. stock price forecast?

ResMed Inc. is currently trading at $193.94. View real-time AI analysis on Alpha Lenz.

What is ResMed Inc. insider trading activity?

View the latest insider trading data for ResMed Inc. on Alpha Lenz.

What is ResMed Inc.'s P/E ratio?

View ResMed Inc.'s valuation metrics on Alpha Lenz.

ResMed Inc.

NYSE · RMD
$193.94+1.20(+0.62%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about ResMed Inc.'s future dividend policy...
Alpha Chat Insight

ResMed Inc.'s ROE is 25.9%. Explore profitability and growth together.

Ask for details

Company Overview

ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producing advanced equipment for sleep apnea therapy, chronic obstructive pulmonary disease (COPD), and various respiratory conditions. The company's offerings include a range of cutting-edge products like continuous positive airway pressure (CPAP) devices, bilevel systems, and ventilators, designed to enhance patient comfort and compliance. ResMed is also at the forefront of integrating cloud-connected devices to support improved patient monitoring and telemedicine services. The healthcare industry, particularly the medical device sector, benefits significantly from ResMed's contributions, as the company aims to address the growing needs associated with sleep and respiratory conditions. By focusing on both personal and overarching health care solutions, ResMed plays a crucial role in enhancing patient quality of life, thereby solidifying its position as a key player in the global health and respiratory care markets.

CEOMr. Michael J. Farrell BE, MBA, SM
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees10,600

Company Statistics

FY 2025

Profile

N/AMarket Cap
$5.15BRevenue
0.00Shares Out
10,600Employees

Margins

59.36%Gross
37.41%EBITDA
32.79%Operating
32.60%Pre-Tax
27.22%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

12.88%Rev 3Yr
11.72%Rev 5Yr
18.97%Op Inc 3Yr
15.84%Op Inc 5Yr
21.58%Net Inc 3Yr
17.64%Net Inc 5Yr

Returns

18.62%ROA
25.86%ROE
22.43%ROIC

Financial Health

$1.21BCash & Cash Equivalents
$997.08MNet Debt
36.97%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

ResMed Inc. (ticker: RMD) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 10,600 employees.

The current price is $193.94 with a P/E ratio of -x and P/B of -x.

ROE is 25.86% and operating margin is 32.79%. Annual revenue is $5.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
ResMed Inc. (RMD) Stock Forecast 2026 $193.94 — Price, Financials & Analyst Targets | Alpha Lenz